Assessing glutamatergic function and dysfunction in peripheral tissues

Current Medicinal Chemistry

Volumn 19, Issue 9, 2012, Pages 1310-1315

  Tremolizzo, L ^a,b   Sala, G ^a   Zoia, C P ^a   Ferrarese, C ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

Cerebrospinal fluid; fibroblasts; glutamate; leukocytes; peripheral markers; plasma; platelets

Indexed keywords

BIOLOGICAL MARKER; GLUTAMIC ACID;

BLOOD CELL; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; ELECTRON MICROSCOPY; FIBROBLAST; HUMAN; LEUKOCYTE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PLASMA; REVIEW; SKIN BIOPSY; THROMBOCYTE;

ANIMALS; BLOOD CELLS; CENTRAL NERVOUS SYSTEM; FIBROBLASTS; GLUTAMIC ACID; HUMANS; PERIPHERAL NERVOUS SYSTEM; SIGNAL TRANSDUCTION; SKIN;

EID: 84858143801     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712799462702     Document Type: Review

References (82)

1. Tremolizzo, L.; Beretta, S.; Ferrarese, C. Peripheral markers of glutamatergic dysfunction in neurological diseases: focus on ex vivo tools. Crit Rev Neurobiol. 2004, 16, 141-146. (Pubitemid 39586912)
2. Hinoi, E.; Takarada, T.; Ueshima, T.; Tsuchihashi, Y.; Yoneda, Y. Glutamate signaling in peripheral tissues. Eur J Biochem. 2004, 271, 1-13. (Pubitemid 38122160)
3. Julio-Pieper, M.; Flor, P.J.; Dinan, T.G.; Cryan, J.F. Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues. Pharmacol Rev. 2011, 63, 35-58.
4. Gill, S.S.; Pulido, O.M. Glutamate receptors in peripheral tissues: current knowledge, future research, and implications for toxicology. Toxicol Pathol. 2001, 29, 208-223. (Pubitemid 32531621)
5. Haas, H.S.; Linecker, A.; Pfragner, R.; Sadjak, A. Peripheral glutamate signaling in head and neck areas. Head Neck. 2010, 32, 1554-1572.
6. Ferrarese, C.; Aliprandi, A.; Tremolizzo, L.; Stanzani, L.; De Micheli, A.; Dolara, A.; Frattola, L. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology. 2001, 57, 671-675. (Pubitemid 32782996)
7. Beretta, S.; Begni, B.; Ferrarese, C. Pharmacological manipulation of glutamate transport. Drug News Perspect. 2003, 16, 435-445. (Pubitemid 37442421)
8. Ferrarese, C.; Beal, M.F., editors. Excitotoxicity in Neurological Diseases: New Therapeutic Challenge. Kluwer Academic Publishers. 2003
9. Ritsner, M.S., editor. Neuropsychiatric Biomarkers, Endophenotypes, and Genes. Springer Science. 2009
10. Takamori, S. VGLUTs: 'exciting' times for glutamatergic research? Neurosci Res. 2006, 55, 343-351. (Pubitemid 43866255)
11. Da Prada, M.; Cesura, A.M.; Launay, J.M.; Richards J.G. Platelets as a model for neurones? Experientia. 1988, 44, 115-126. (Pubitemid 18074244)
12. Di Luca, M.; Colciaghi, F.; Pastorino, L.; Borroni, B.; Padovani, A.; Cattabeni, F. Platelets as a peripheral district where to study pathogenetic mechanism of Alzheimer disease: the case of amyloid precursor protein. Eur J Pharmacol. 2000, 405, 277-283.
13. Yang, M.; Srikiatkhachorn, A.; Anthony, M.; Chong, B.H. Serotonin stimulates megakaryocytopoiesis via the 5-HT2 receptor. Blood Coagul Fibrinolysis. 1996, 7, 127-133. (Pubitemid 26171521)
14. Mangano, R.M.; Schwarcz, R. The human platelet as a model for the glutamatergic neuron: platelet uptake of L-Glutamate. J Neurochem. 1981, 36, 1067-1076. (Pubitemid 11100094)
15. D'Andrea, G.; Canazi, A.R.; Ferro-Milone, F.; Joseph, R.; Grunfeld, S.; Welch, K.M. Platelet levels of glutamate and aspartate in normal subjects. Stroke. 1989, 20, 299-300.
16. Tremolizzo, L.; DiFrancesco, J.C.; Rodriguez-Menendez, V.; Sirtori, E.; Longoni, M.; Cassetti, A.; Bossi, M.; El Mestikawy, S.; Cavaletti, G.; Ferrarese, C. Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation. Neurosci Lett. 2006, 404, 262-265. (Pubitemid 44108439)
17. Tremolizzo, L.; Piazza, F.; Longoni, M.; Ferrarese, C. Platelets might mediate the increase of plasma glutamate in acute ischemic stroke: relevance for early neurological deterioration. Med Hypotheses. 2009, 73, 553-554.
18. Skerry, T.M.; Genever, P.G. Glutamate signalling in non-neuronal tissues. Trends Pharmacol Sci. 2001, 22, 174-181. (Pubitemid 32244303)
19. Morrell, C.N.; Sun, H.; Ikeda, M.; Beique, J.C.; Swaim, A.M.; Mason, E.; Martin, T.V.; Thompson, L.E.; Gozen, O.; Ampagoomian, D.; Sprengel, R.; Rothstein, J.; Faraday, N.; Huganir, R.; Lowenstein, C.J. Glutamate mediates platelet activation through the AMPA receptor. J Exp Med. 2008, 205, 575-584. (Pubitemid 351439305)
20. Genever, P.G.; Wilkinson, D.J.; Patton, A.J.; Peet, N.M.; Hong, Y.; Mathur, A.; Erusalimsky, J.D.; Skerry, T.M. Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. Blood. 1999, 93, 2876-2883. (Pubitemid 29200778)
21. Reilmann, R.; Rolf, L.H.; Lange, H.W. Huntington's disease: N-methyl-D-aspartate receptor coagonist glycine is increased in platelets. Exp Neurol. 1997, 144, 416-419. (Pubitemid 27224568)
22. Tremolizzo, L.; Sala, G.; Ferrarese, C. Platelets. In: Stolerman, I.P. (ed.), Encyclopedia of Psychopharmacology. Springer-Verlag Berlin Heidelberg. 2010
23. Franconi, F.; Miceli, M.; De Montis, M.G.; Crisafi, E.L.; Bennardini, F.; Tagliamone, A. NMDA receptors play an antiaggregating role in human platelets. Thromb Haemost. 1996, 76, 84-87.
24. Franconi, F.; Miceli, M.; Alberti, L.; Seghieri, G.; De Montis, M.G.; Tagliamone, A. Further insights into the anti-aggregating activity of NMDA in human platelets. Br J Pharmacol. 1998, 124, 35-40.
25. Sun, H.; Swaim, A.; Herrera, J.E.; Becker, D.; Becker, L.; Srivastava, K.; Thompson, L.E.; Shero, M.R.; Perez-Tamayo, A.; Suktitipat, B.; Mathias, R.; Contractor, A.; Faraday, N.; Morrell, C.N. Platelet kainate receptor signaling promotes thrombosis by stimulating cyclooxygenase activation. Circ Res. 2009, 105, 595-603.
26. Baier, P.C.; Koch, J.M.; Seeck-Hirschner, M.; Ohlmeyer, K.; Wilms, S.; Aldenhoff, J.B.; Hinze-Selch, D. A flow-cytometric method to investigate glutamate-receptor-sensitivity in whole blood platelets - results from healthy controls and patients with schizophrenia. J Psychiatr Res. 2009, 43, 585-591.
27. Berk, M.; Plein, H.; Ferreira, D. Platelet glutamate receptor supersensitivity in major depressive disorder. Clin Neuropharmacol. 2001, 24, 129-132. (Pubitemid 32549986)
28. Zoia, C.; Cogliati, T.; Tagliabue, E.; Cavaletti, G.; Sala, G.; Galimberti, G.; Rivolta, I.; Rossi, V.; Frattola, L:; Ferrarese, C. Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease. Neurobiol Aging. 2004, 25, 149-157.
29. Begni, B.; Tremolizzo, L.; D'Orlando, C.; Bono, M.S.; Garofolo, R.; Longoni, M.; Ferrarese, C. Substrate-induced modulation of glutamate uptake in human platelets. Br J Pharmacol. 2005, 145, 792-799. (Pubitemid 41076286)
30. Borges, V.C.; Santos, F.W.; Rocha, J.B.; Nogueira, C.W. Heavy metals modulate glutamatergic system in human platelets. Neurochem Res. 2007, 32, 953-958. (Pubitemid 46726013)
31. Ferrarese, C.; Begni, B.; Canevari, C.; Zoia, C.; Piolti, R.; Frigo, M.; Appollonio, I.; Frattola, L. Glutamate uptake is decreased in platelets from Alzheimer's disease patients. Ann Neurol. 2000, 47, 641-643. (Pubitemid 30261900)
32. Ferrarese, C.; Zoia, C.; Pecora, N.; Piolti, R.; Frigo, M.; Bianchi, G.; Sala, G.; Begni, B.; Riva, R.; Frattola, L. Reduced platelet glutamate uptake in Parkinson's disease. J Neural Transm. 1999, 106, 685-692. (Pubitemid 29401356)
33. Ferrarese, C.; Sala, G.; Riva, R.; Begni, B.; Zoia, C.; Tremolizzo, L.; Galimberti, G.; Millul, A.; Bastone, A.; Mennini, T.; Balzarini, C.; Frattola, L.; Beghi, E.; Italian ALS Study Group. Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology. 2001, 56, 270-272.
34. Vaccaro, M.; Riva, C.; Tremolizzo, L.; Longoni, M.; Aliprandi, A.; Agostoni, E.; Rigamonti, A.; Leone, M:; Bussone, G.; Ferrarese, C. Platelet glutamate uptake and release in migraine with and without aura. Cephalalgia. 2007, 27, 35-40.
35. Aliprandi, A.; Longoni, M.; Stanzani, L.; Tremolizzo, L.; Vaccaro, M.; Begni, B.; Galimberti, G.; Garofolo, R.; Ferrarese, C. Increased plasma glutamate in stroke patients might be linked to altered platelet release and uptake. J Cereb Blood Flow Metab. 2005, 25, 513-519.
36. D'Andrea, D.; Nordera, G.P.; Allais, G. Treatment of aura: solving the puzzle. Neurol Sci 2006, 27 (Suppl. 2), s96-99.
37. Mallolas, J.; Hurtado, O.; Castellanos, M.; Blanco, M.; Sobrino, T.; Serena, J.; Vivancos, J.; Castello, J.; Lizasoain, I.; Moro, M.A.; Dávalos, A. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J Exp Med 2006, 203, 711-717.
38. do Nascimento, C.A.; Nogueira, C.W.; Borges, V.C.; Rocha, J.B. Changes in [(3)H]-glutamate uptake into platelets from patients with bipolar I disorder. Psychiatry Res. 2006, 141, 343-347.
39. Rainesalo, S.; Keränen, T.; Peltola, J.; Saransaari, P. Glutamate uptake in blood platelets from epileptic patients. Neurochem Int. 2003, 43, 389-392. (Pubitemid 36561292)
40. Sarchielli, P.; Di Filippo, M.; Candeliere, A.; Chiasserini, D.; Mattioni, A.; Tenaglia, S.; Bonucci, M.; Calabresi, P. Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. J Neuroimmunol. 2007, 188, 146-158. (Pubitemid 47095024)
41. Yong, V.W.; Rivest, S. Taking advantage of the systemic immune system to cure brain diseases. Neuron. 2009, 64, 55-60.
42. Lombardi, G.; Dianzani, C.; Miglio, G.; Canonico, P.L.; Fantozzi, R. Characterization of ionotropic glutamate receptors in human lymphocytes. Br J Pharmacol. 2001, 133, 936-944. (Pubitemid 32751804)
43. Ganor, Y.; Besser, M.; Ben-Zakay, N.; Unger, T.; Levite, M. Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J Immunol. 2003, 170, 4362-4372. (Pubitemid 36428206)
44. Chiocchetti, A.; Miglio, G.; Mesturini, R.; Varsaldi, F.; Mocellin, M.; Orilieri, E.; Dianzani, C.; Fantozzi, R.; Dianzani, U.; Lombardi, G. Group I mGlu receptor stimulation inhibits activation-induced cell death of human T lymphocytes. Br J Pharmacol. 2006, 148, 760-768. (Pubitemid 44079405)
45. Miglio, G.; Varsaldi, F.; Dianzani, C.; Fantozzi, R.; Lombardi, G. Stimulation of group I metabotropic glutamate receptors evokes calcium signals and c-jun and c-fos gene expression in human T cells. Biochem Pharmacol. 2005, 70, 189-199. (Pubitemid 40814401)
46. Miglio, G.; Varsaldi, F.; Lombardi, G. Human T lymphocytes express N-methyl-D-aspartate receptors functionally active in controlling T cell activation. Biochem Biophys Res Commun. 2005, 338, 1875-1883. (Pubitemid 41643104)
47. Sturgill, J.L.; Mathews, J.; Scherle, P.; Conrad, D.H. Glutamate signaling through the kainate receptor enhances human immunoglobulin production. J Neuroimmunol. 2011, 233, 80-89.
48. Poulopoulou, C.; Davaki, P.; Koliaraki, V.; Kolovou, D.; Markakis, I.; Vassilopoulos, D. Reduced expression of metabotropic glutamate receptor 2mRNA in T cells of ALS patients. Ann Neurol. 2005, 58, 946-949. (Pubitemid 41746885)
49. Kravos, M.; Malesic, I. Glutamate dehydrogenase activity in leukocytes and ageing. Neurodegener Dis. 2010, 7, 239-242.
50. Duvoisin, R.C.; Nicklas, W.J.; Ritchie, V.; Sage, J.; Chokroverty, S. Low leukocyte glutamate dehydrogenase activity does not correlate with a particular type of multiple system atrophy. J Neurol Neurosurg Psychiatry. 1988, 51, 1508-1511. (Pubitemid 19026521)
51. Chokroverty, S.; Nicklas, W.; Miller, D.C.; Goldberg, J.; Choe, J.; Banner, C.; Thomas, J.; Duvoisin, R. Multiple system degeneration with glutamate dehydrogenase deficiency: pathology and biochemistry. J Neurol Neurosurg Psychiatry. 1990, 53, 1099-1101.
52. Gonçalves, A.; Oliveira, C.; Ferro, M.A.; Dinis, M.; Cunha, L. Glutamate dehydrogenase deficiency in Machado-Joseph disease. Can J Neurol Sci. 1993, 20, 147-150. (Pubitemid 23212868)
53. Hugon, J.; Tabaraud, F.; Rigaud, M.; Vallat, J.M.; Dumas, M. Glutamate dehydrogenase and aspartate aminotransferase in leukocytes of patients with motor neuron disease. Neurology. 1989, 39, 956-958. (Pubitemid 19170421)
54. Castillo, J.; Davalos, A.; Naveiro, J.; Noya, M. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 1996, 27, 1060-1065. (Pubitemid 26177607)
55. Castillo, J.; Davalos, A.; Noya, M. Progression of ischaemic stroke and excitotoxic aminoacids. Lancet 1997, 349, 79-83. (Pubitemid 27023423)
56. Plaitakis, A.; Caroscio, J.T. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1987, 22, 575-579. (Pubitemid 17162898)
57. Shaw, P.J.; Forrest, V.; Ince, P.G.; Richardson, J.P.; Wastell, H.J. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration. 1995, 4, 209-216.
58. Perry, T.L.; Krieger, C.; Hansen, S.; Eisen, A. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid. Ann Neurol. 1990, 28, 12-17. (Pubitemid 20222146)
59. Camu, W.; Billiard, M.; Baldy-Moulinier, M. Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis. Acta Neurol Scand. 1993, 88, 51-55. (Pubitemid 23210976)
60. Rothstein, J.D.; Tsai, G.; Kuncl, R.W.; Clawson, L.; Cornblath, D.R.; Drachman, D.B.; Pestronk, A.; Stauch, B.L.; Coyle, J.T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1990, 28, 18-25. (Pubitemid 20222147)
61. Rothstein, J.D.; Martin, L.J.; Kuncl, R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med. 1992, 326, 1464-1468.
62. Janjua, N.A.; Itano, T.; Kugoh, T.; Hosokawa, K.; Nakano, M.; Matsui, H.; Hatase, O. Familial increase in plasma glutamic acid in epilepsy. Epilepsy Res. 1992, 11, 37-44.
63. Ohnuma, T.; Arai, H. Significance of NMDA receptor-related glutamatergic amino acid levels in peripheral blood of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 15, 29-39.
64. Hoekstra, R.; Fekkes, D.; Loonen, A.J.; Pepplinkhuizen, L.; Tuinier, S.; Verhoeven, W.M. Bipolar mania and plasma amino acids: increased levels of glycine. Eur Neuropsychopharmacol. 2006, 16, 71-77. (Pubitemid 43005097)
65. Ferrarese, C.; Pecora, N.; Frigo, M.; Appollonio, I.; Frattola, L. Assessment of reliability and biological significance of glutamate levels in cerebrospinal fluids. Ann Neurol 1993, 33, 313-369.
66. Connolly, G.P. Fibroblast models of neurological disorders: fluorescence measurement studies. Trends Pharmacol Sci. 1998, 19, 171-177. (Pubitemid 28255403)
67. Vanier, M.T. Niemann-Pick disease type C. Orphanet J Rare Dis. 2010, 5, 16.
68. Balcar, V.J.; Shen, J.; Bao, S.; King, N.J. Na(+)-dependent high affinity uptake of L-glutamate in primary cultures of human fibroblasts isolated from three different types of tissue. FEBS Lett. 1994, 339, 50-54.
69. Zoia, C.P.; Tagliabue, E.; Isella, V.; Begni, B.; Fumagalli, L.; Brighina, L.; Appollonio, I.; Racchi, M.; Ferrarese, C. Fibroblast glutamate transport in aging and in AD: correlations with disease severity. Neurobiol Aging. 2005, 26, 825-832. (Pubitemid 40249484)
70. Zoia, C.P.; Riva, C.; Isella, V.; Proserpio, P.; Terruzzi, A.; Arban, S.; Salerno, D.; Cassina, V.; Mantegazza, F.; Tremolizzo, L.; Ferrarese, C. Nonfibrillar Abeta1-42 inhibits glutamate uptake and phosphorylates p38 in human fibroblasts. Alzheimer Dis Assoc Disord. 2011, 25, 164-172.
71. Okutsu, S.; Hatakeyama, H.; Kanzaki, M.; Tsubokawa, H.; Nagatomi, R. Electric pulse stimulation induces NMDA glutamate receptor mRNA in NIH3T3 mouse fibroblasts. Tohoku J Exp Med. 2008, 215, 181-187.
72. May, P.C.; Gray, P.N. The mechanism of glutamate-induced degeneration of cultured Huntington's disease and control fibroblasts. J Neurol Sci. 1985, 70, 101-112. (Pubitemid 15019904)
73. Gray, P.N.; May, P.C.; Mundy, L.; Elkins, J. L-Glutamate toxicity in Huntington's disease fibroblasts. Biochem Biophys Res Commun. 1980, 95, 707-714. (Pubitemid 10016850)
74. Zeng, Y.; Lv, X.; Zeng, S.; Shi, J. Activity-dependent neuronal control of gap-junctional communication in fibroblasts. Brain Res. 2009, 1280, 13-22.
75. Beretta, S.; Mattavelli, L.; Sala, G.; Tremolizzo, L.; Schapira, A.H.; Martinuzzi, A.; Carelli, V.; Ferrarese, C. Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines. Brain. 2004, 127, 2183-2192. (Pubitemid 39382227)
76. DiFrancesco, J.C.; Cooper, J.M.; Lam, A.; Hart, P.E.; Tremolizzo, L.; Ferrarese, C.; Schapira, A.H. MELAS mitochondrial DNA mutation A3243G reduces glutamate transport in cybrids cell lines. Exp Neurol. 2008, 212, 152-156.
77. Volterra, A.; Trotti, D.; Racagni, G. Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms. Mol Pharmacol. 1994, 46, 986-992. (Pubitemid 24364115)
78. Kent LW, Dyken RA, Rahemtulla F, Allison AC, Michalek SM. Effect of in vitro passage of healthy human gingival fibroblasts on cellular morphology and cytokine expression. Arch Oral Biol. 1996, 41, 263-270. (Pubitemid 126652119)
79. Marchesi, C.; Dall'Asta, V.; Rotoli, B.M.; Bianchi, M.G.; Maggini, C.; Gazzola, G.C.; Bussolati, O. Chlorpromazine, clozapine and olanzapine inhibit anionic amino acid transport in cultured human fibroblasts. Amino Acids. 2006, 31, 93-99. (Pubitemid 44222571)
80. Joseph, R.; Tsering, C.; Grunfeld, S.; Welch, K.M. Platelet secretory products may contribute to neuronal injury. Stroke. 1991, 22, 1448-1451.
81. Pacheco, R; Gallart, T; Lluis, C; Franco, R. Role of glutamate on T-cell mediated immunity. J Neuroimmunol. 2007, 185, 9-19. (Pubitemid 46497434)
82. Smith, Q.R. Transport of glutamate and other amino acids at the blood-brain barrier. J Nutr. 2000, 130, 1016S-1022S. (Pubitemid 30173636)